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Background: Situs inversus totalis represents an unusual anomaly characterized by a mirror-image transposition of
the abdominal and thoracic viscera. It often occurs concomitantly with other disorders that make difficult diagnosis
and management of abdominal pathology. The relationship between situs inversus totalis and cancer remains
unclear.
Case presentation: We describe a 33-year old Guinean man with situs inversus totalis who presented with
obstructive jaundice. Imaging and endoscopic modalities demonstrated a mass of distal common bile duct which
biopsy identified an adenocarcinoma. The patient was successfully treated by cephalic pancreaticoduodenectomy
followed by adjuvant chemoradiation and he is doing well without recurrence 8 months after surgery.
Conclusion: The occurrence of bile duct adenocarcinoma in patient with situs inversus totalis accounts as a rare
coincidence. In this setting, when the tumor is resectable, surgical management should be considered without
contraindication and must be preceded by a careful preoperative staging.
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Situs inversus totalis (SIT) is a rare congenital condition
characterized by a mirror-image transposition of both
the abdominal and thoracic viscera, its incidence
accounts for 1/8000 to 1/25,000 of the normal popula-
tion [1]. This condition may cause difficulties in the
diagnosis and therapeutic management of abdominal
pathology [2,3]. An increased risk of cardiac, splenic and
hepatobiliary malformations are found in patients with
SIT [4]; this abnormality is not considered to be a pre-
malignant entity, however rare malignant neoplasms
have been reported. A case of successfully treated com-
mon bile duct adenocarcinoma in a 33-year old man
with SIT, an association described for the fourth time in
the literature, is described.
Case report
A 33-year old previously healthy man, with known SIT
presented with 3 months history of obstructive jaundice* Correspondence: hafida.benhammane@gmail.com
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distribution, and reproduction in any mediumand 10 Kg weight loss. Computed tomography (CT)
confirmed the complete transposition of viscera as fol-
lows: dextrocardia, right subphrenic gastric bubble and
spleen with a small accessory spleen, left sided liver and
reversed superior vena cava, brachiocephalic artery
and hepatic artery; CT also revealed a dilatation of intra
and extra hepatic bile ducts secondary to stenosis of the
distal common bile duct (CBD) (Figure 1). Magnetic res-
onance cholangiopancreatography confirmed the tapered
stricture of the CBD with upstream dilation of the bile
ducts (Figure 2A); Endoscopic ultrasound showed a
15 mm seized hypoechoic mass at the distal portion of
the CBD (Figure 2B), which biopsies identified an
adenocarcinoma with a strong positivity for Pancytoker-
atin. Staging showed no distant metastasis and serum
levels of carbohydrate antigen 19-9 and carcinoembryo-
nic antigen were normal. As the patient refused ini-
tially surgical management, an Endoscopic Retrograde
Cholangio-Pancreatography (ERCP) with placement of
biliary stent was performed (Figure 3); one year later
the patient developed an iatrogenic acute pancreatitis
and he finally agreed to the surgical approach. Follow-
ing a left subcostal laparotomy, he underwent cephalicentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 A: Computed tomography during portal phase shows heterotopic location of the liver, the stomach and the spleen. The
intrahepatic bile ducts are mildly dilated (black arrow). B: There is also a small accessory spleen between the tail of the pancreas and the spleen
(white arrow). L: liver; St: stomach; Sp: spleen; P: pancreas.
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nodes and partial resection of portal and splenomesaraic
vein, which were found to be invaded by the tumor. The
procedure was evidently difficult and unusual because of
the situs inversus. Histological analysis of the specimen
resection confirmed the diagnosis of a well differentiated
adenocarcinoma of CBD infiltrating the head of pancreas
(Figure 4) with 5 metastatic lymph nodes in the retro-
portal lamina; biliary, pancreatic, duodenal and retro-
peritoneal margins were free of tumor, however the
tumor was found to have invaded the venous section
margin. The tumor was classified as pT3N1M0. The
postoperative course was uneventful. Regarding the posi-
tive margin, complementary radiation with concurrent
chemotherapy based on capecitabin was administrated.
Currently, the patient is fit without any evidence of re-
currence 8 months after surgical treatment.
Discussion
Situs inversus is an uncommon congenital condition
which is defined by a left-right transposition of the nor-
mally asymmetrical organs of the body as a mirror-
image; transposition of thoracic and abdominal organs isFigure 2 A: Magnetic resonance cholangiopancreatography shows a
dilation of the bile ducts. B: Endoscopic ultrasonography shows an hypo
the dilated common bile duct. GB: gallbladder; W: Wirsung duct; CBD: comtermed situs inversus totalis [1]. This form occurs with a
frequency of 1/ 8000 to 1/25000 and is characterized by
dextrocardia with complete reversal of the heart cham-
bers, the aorta turns to the right, the left lung has 3
lobes and the right lung only 2 [1,5]. In the abdomen,
the stomach, spleen and pancreas are right sided of the
body, the liver and gallbladder are left sided, the colonic
flexures are reversed [4-6]. SIT occurs frequently with
other disorders including Kartagener’s syndrome, pri-
mary ciliary dyskinesia, syndrome of asplenia or poly-
splenia as seen in our patient [1,4,7]. These anomalies
are commonly associated with cardiovascular malforma-
tions which are more severe in the case of asplenia than
in polysplenia [8]. The other anomalies include short
pancreas, symmetric lobulation of the liver, biliary atre-
sia, absence of the gallbladder and genitourinary anom-
alies; blood vessels, nerves and lymphatic are also
transposed [1,7]. Pathogenic mechanisms of SIT have
not been well elucidated. Some genetic patterns are
involved including an autosomal recessive gene located
to chromosome 14 [9] and deletions affecting chromo-
somes 7 or 8 [10]; Recently, significant advancements in
understanding the possible molecular pathways weretapered stricture of the common bile duct (arrows) with upstream
echoic nodule (arrow) within the head of the pancreas and close to
mon bile duct.
Figure 3 A: Endoscopic retrograde cholangiopancreatography confirms the stricture of the common bile duct (arrows). B: endoscopic
view showing stenosis of distal common bile duct with placement of biliary stent.
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DNAH11 genes are involved in autosomal recessive lat-
erality defects of diverse phenotype resulting in SIT
[11,12]. In addition, it has been shown that mutations in
the TGF- β family gene and in the transcription factor
HNF-3 β have a probable role in the process [13].
The association of SIT and neoplasia is a rare coinci-
dence; only sporadic cases have been reported. The first
case was published by Maekawa in 1927; it was an aut-
opsy case of gastric carcinoma in a 43-year-old man with
SIT [14]. SIT is not considered a premalignant condi-
tion; however, despite its rarity and regarding the non-
negligible number of published sporadic cases of cancer
in this setting, a relationship between situs abnormalities
and cancer has been suggested. Some authors postulate
that unidentified genes involved in left-right arrange-
ment may have susceptibility of cancer like CCDC11Figure 4 Well differentiated adenocarcinoma centered by the commo
pancreatic parenchyma. At the upper left of the image, morphology of tgene that mutation or loss expression is involved in
some cancers [15,16]; in addition, it has been suggested
that ciliary dysfunction via dysregulation of the hedge-
hog pathway may be the underlying cause of SIT [17], so
Tomohiro et al. report that patients with SIT may
be at high risk of developing cancer due to a congenital
deficiency in the function of an intracellular protein,
necessary to ciliogenesis, namely the KIF3 complex
[18] leading to a ciliary dysfunction with a chronic in-
flammation which promote carcinogenesis via the pro-
inflammatory nuclear factor kappa B [19]. These hypoth-
eses remain not well elucidated and further research is
needed to assess the genetic association between SIT
and malignancy. Many different cancers have been
reported (cancer of stomach, colon, pancreas, biliary
tract, ampulla of Vater, and kidney). Biliary tract carcin-
omas are relatively rare, representing less than 1% ofn bile duct with very discrete infiltration of the surounding
he tumor at high magnification.
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noma account for 4% and 3% of all gastrointestinal can-
cers respectively [20]. CT scan and ERCP are required
for diagnosis and staging [21]. Complete surgical resec-
tion is the only potentially curative treatment available
for resectable disease leading to 5-year survival rates of
5–10% for gallbladder cancer and 10–40% for cholangio-
carcinoma [20,21]. In the setting of SIT, only three cases
have been reported which were all cholangiocarcinoma
[22-24]; herein we describe this association for the
fourth time in literature; no case of gallbladder carcin-
oma has been reported. Careful preoperative staging by
imaging modalities is important prior to invasive proce-
dures in cancer patients with SIT in order to understand
anatomic abnormalities [2,15]. Evidently, SIT makes the
surgical procedure challenging because of the difficulties
in following surgical protocols in this situation. However,
the presence of anatomic variations should not modify
the principles of oncologic surgery.
Conclusion
SIT is an uncommon entity that often occurs concomi-
tantly with other abnormalities. The relationship be-
tween SIT and cancer is not approved; further, studies
are needed to identify precisely genetic and molecular
patterns involved in development of malignancy in these
patients. Because of the frequency of associated malfor-
mations of transposed organs and vascular and nervous
anatomical variations that make difficult surgical man-
agement, special attention should be paid to the diagno-
sis and preoperative staging. Herein, we have described
for the fourth time in the literature a case of unusual as-
sociation of SIT and adenocarcinoma of common bile
duct.
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